Kronos Bio Inc

-0.08 (-4.02%)
Earnings Announcements

Kronos Bio Reports Q3 Net Loss Of $0.57 Per Share

Published: 11/08/2022 22:55 GMT
Kronos Bio Inc (KRON) - Kronos Bio Reports Recent Business Progress and Third-quarter 2022 Financial Results.
Kronos Bio Inc - $270.3 Million in Cash, Cash Equivalents and Investments As of Sept.
30, 2022, With Expected Cash Runway Into Q2 2025.
Kronos Bio Inc - Net Loss for Q3 of 2022 Was $32.3 Million, Or $0.57 per Share.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.62

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.57

More details on our Analysts Page.